Thoracic/Respiratory

The medical devices giant that is Covidien, shows its still on the acquisition trail with the announcement that it is to spend $300M buying Israeli respiratory monitoring company Oridion.

The Society for Cardiothoracic Surgery in Great Britain and Ireland welcomes Cardiothoracic Anaesthetists Society (ACTA) to join its annual meeting and Cardiothoracic forum in Manchester later this month.

Crux’s Vena Cava Filter is looking like a winner with good investigator feedback and clinical results as reported at last week’s Society of Interventional Radiology meeting in San Francisco.

Treatment decisions or sleep apnea sufferers need no longer be quite so hit and miss as FDA clears Somnomed’s MATRx device for predicting outcome of Oral Appliance Therapy

Another Covidien Acquisition, this time in its Airway and Ventilation Business, with announced purchase of Newport Medical Inc.

Covidien in the news again, this time with UK recall of LigaSure Dolphin Tip Sealer for fear of loose pins in the handle.

Covidien is back in the news this week with its announcement of the acquisition of Israeli pulmonology company superDimension Ltd.

It’s AATS time again. This year the Thoracic specialty heads for San Francisco’s Moscone Convention Center on April 28th.

Covidien showcased its new iterations of trocar and tissue sealer at SAGES.

Acclarent’s voluntary recall of its Inspira Air™ balloon dilatation system has been formalised as a FDA Class 1 recall.

Christopher Lyles, the first American recipient of a seeded tracheal transplant has passed away this week.

Ethicon-Endo-supported retrospective data study says VATS is cheaper and better than open wedge resection.

It’s only a month, but when people have died because of a medical device technology being found wanting, shouldn’t the UK’s competent authority have acted sooner?

Despite losing Hemostase revenue, Cryolife has reported record Q4 and significant annual revenue growth, giving it optimistic outlook for the near term as it enacts global strategic initiatives.

Crux Biomedical has announced it has received CE mark approval for its revolutionary inferior vena cava filter with bi-directional retrieval.

Interview with the team leader behind tracheal transplant case in Stockholm, first reported a few weeks ago.